Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate

被引：24
|
作者：
Poggio, F. [1 ]
Tagliamento, M. [2 ,3 ]
Ceppi, M. [4 ]
Bruzzone, M. [4 ]
Conte, B. [1 ,2 ]
Fregatti, P. [5 ,6 ]
Punie, K. [7 ,8 ]
de Azambuja, E. [9 ]
Del Mastro, L. [2 ,10 ]
Lambertini, M. [2 ,11 ]
机构：
[1] IRCCS Osped Policlin San Martino, Oncol Med 2, Genoa, Italy
[2] Univ Genoa, Sch Med, Dept Internal Med & Med Specialties DiMI, Genoa, Italy
[3] Gustave Roussy, Dept Canc Med, Villejuif, France
[4] IRCCS Osped Policlin San Martino, Clin Epidemiol Unit, Genoa, Italy
[5] IRCCS Osped Policlin San Martino, Dept Surg, UOC Clin Chirurg Senol, Genoa, Italy
[6] Univ Genoa, Sch Med, Dept Integrated Diagnost Surg Sci, Genoa, Italy
[7] Univ Hosp Leuven, Leuven Canc Inst, Dept Gen Med Oncol, Leuven, Belgium
[8] Univ Hosp Leuven, Leuven Canc Inst, Multidisciplinary Breast Ctr, Leuven, Belgium
[9] Univ Libre Bruxelles ULB, Inst Jules Bordet, Brussels, Belgium
[10] IRCCS Osped Policlin San Martino, Breast Unit, Genoa, Italy
[11] IRCCS Osped Policlin San Martino, Dept Med Oncol, UOC Clin Oncol Med, Genoa, Italy
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 03期
关键词：
D O I：
10.1016/j.annonc.2021.11.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：347 / 349
页数：3
相关论文
共 50 条
  • [1] Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the die has not been cast
    Tomasik, B.
    Bienkowski, M.
    Jassem, J.
    ANNALS OF ONCOLOGY, 2022, 33 (06) : 658 - 659
  • [2] Most neoadjuvant chemotherapy for triple-negative breast cancer should include platinum
    Dent, Rebecca
    LANCET ONCOLOGY, 2021, 22 (01): : 27 - 28
  • [3] Platinum chemotherapy for early triple-negative breast cancer
    Mason, Sofia RE.
    Willson, Melina L.
    Egger, Sam J.
    Beith, Jane
    Dear, Rachel F.
    Goodwin, Annabel
    BREAST, 2024, 75
  • [4] Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer
    Stover, Daniel G.
    Bell, Caitlin F.
    Tolaney, Sara M.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 6 - 12
  • [5] Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy
    Marra, Antonio
    Curigliano, Giuseppe
    CANCER JOURNAL, 2021, 27 (01): : 41 - 49
  • [6] Addition of platinum salts to neoadjuvant chemotherapy in triple-negative breast cancer: a new standard of care?
    Curigliano, Giuseppe
    LANCET ONCOLOGY, 2018, 19 (04): : 434 - 436
  • [7] Platinum-based chemotherapy in triple-negative breast cancer
    Sirohi, B.
    Arnedos, M.
    Popat, S.
    Ashley, S.
    Nerurkar, A.
    Walsh, G.
    Johnston, S.
    Smith, I. E.
    ANNALS OF ONCOLOGY, 2008, 19 (11) : 1847 - 1852
  • [8] Platinum-Based Chemotherapy in Triple-Negative Breast Cancer
    Villarreal-Garza, C.
    Bouganim, N.
    Khalaf, D.
    Clemons, M.
    Kassam, F.
    Enright, K.
    Verma, S.
    Myers, J.
    Dent, R.
    CANCER RESEARCH, 2011, 71
  • [9] Platinum-based chemotherapy in triple-negative breast cancer
    Villarreal-Garza, C. M.
    Clemons, M.
    Kassam, F.
    Enright, K.
    Verma, S.
    Myers, J. A.
    Dent, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] A meta-analysis of platinum-based neoadjuvant chemotherapy versus standard neoadjuvant chemotherapy for triple-negative breast cancer
    Wang, Dong
    Feng, Jiafu
    Xu, Bei
    FUTURE ONCOLOGY, 2019, 15 (23) : 2779 - 2790
12345